Solid execution and cost disciplinePoised for next phase of Transformational JourneyThird Quarter 2024 Financial Highlights:Net Revenues of ...
Upcoming oral presentation for the ALLOHA TM Phase 1 heme trial at the 66 th American Society of Hematology (ASH) Annual Meeting and Exposition Company to host virtual ... treatment-arm patients and ...
From its previous share price of Rs 35.52 to Rs 39.59, the stock price of Hardwyn India Ltd. grew by almost 11.5%. Days after ...
Announced additional interim data from ongoing Phase 1 clinical study of ORX750, a novel orexin receptor 2 (OX2R) agonist, in ...
During today’s presentation all parties will ... MANTIS opened doors with several high-profile customers, establishing our ...
At this time, all participants are in a listen-only mode. Later, there will be a question-and-answer session, and instructions will be given at that time. Please note that today's call is being ...
[Operator Instructions] After today's presentation ... company to evaluate Matrix-M in a bacterial vaccine program. We intend to continue to seek out similar opportunities to further leverage Matrix-M ...
Research and development expenses increased to $17.0 million for the three months ended September 30, 2024 from $15.4 million for the three months ended September 30, 2023 primarily due to ...
Solid execution and cost disciplinePoised for next phase of Transformational Journey Third Quarter 2024 Financial Highlights: Net Revenues of $1,333 million for the third quarter of 2024 were down ...
Breaking into the design industry can be challenging, especially as trends and technologies evolve. The digital landscape ...
As we recently announced, Absci is collaborating with Twist to design a novel antibody ... studies as planned and our company and our program's ability to potentially demonstrate a truly ...
Net income: The net income attributable to Serina for the three months ended September 30, 2024 was $1.4 million, or $0.16 per share (basic) and $0.13 per share (diluted) compared to net income of ...